Vincent Stoll received his Ph.D. from Albert Einstein College of Medicine in New York in 1990 in mechanistic enzymology and biochemistry with Prof. John Blanchard. He began his post-doctoral studies at the Max Plank Institute for Medical Research, in Heidelberg Germany in 1990 until 1992 using Protein X-ray Crystallography to study flavoprotein oxido-reductases with Prof. Emil Pai. He continued with Prof. Pai from 1992-1997 at the University of Toronto in Canada continuing work with Protein X-ray Crystallography on D-lactate dehydrogenase, structure-based drug design on proteases and protein engineering to modulate chiral substrate preferences of enzymes.
In 1997 Vincent joined Abbott Laboratories in the Structural Biology Group and is now the Associate Director and Research Fellow of Structural Biology at AbbVie (post split from Abbott). While at AbbVie, Vincent has specialized in structure-based drug design on a wide range of anti-viral, oncology, neuroscience and immunology programs in Pharmaceutical Discovery. He has 7 issued patents and over 50 publications.